DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know

Company Performance - DaVita HealthCare (DVA) closed at $143.96, reflecting a +0.94% increase from the previous day's close, outperforming the S&P 500's daily gain of 0.44% [1] - The stock has decreased by 0.9% over the past month, underperforming the Medical sector's gain of 1.16% and the S&P 500's gain of 10.62% [1] Upcoming Earnings - The upcoming earnings report for DaVita HealthCare is scheduled for May 12, 2025, with an expected EPS of $1.75, indicating a 26.47% decline compared to the same quarter last year [2] - The consensus estimate for quarterly revenue is $3.21 billion, representing a 4.59% increase from the previous year [2] Annual Forecast - Zacks Consensus Estimates project earnings of $10.76 per share and revenue of $13.46 billion for the entire year, reflecting changes of +11.16% and +5.05%, respectively, compared to the previous year [3] Analyst Revisions - Recent revisions to analyst forecasts for DaVita HealthCare are important as they reflect short-term business trends, with positive revisions indicating analysts' confidence in the company's performance [4] Zacks Rank and Valuation - DaVita HealthCare currently holds a Zacks Rank of 3 (Hold), with the consensus EPS estimate remaining unchanged over the last 30 days [6] - The company is trading at a Forward P/E ratio of 13.25, which is lower than the industry average Forward P/E of 21.23 [7] - The PEG ratio for DaVita HealthCare is 1.05, compared to the industry average PEG ratio of 1.91 [8] Industry Context - The Medical - Outpatient and Home Healthcare industry, which includes DaVita HealthCare, has a Zacks Industry Rank of 53, placing it in the top 22% of over 250 industries [9]